发布求助
文献互助 智能选刊 最新文献

Info Onkologie最新文献

筛选
英文 中文
Holen sich Brusttumoren Zellen aus dem Knochenmark zur Hilfe? 胸部肿瘤细胞能否从骨髓取出来?
Info Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15004-018-6330-y
M. Borchers
{"title":"Holen sich Brusttumoren Zellen aus dem Knochenmark zur Hilfe?","authors":"M. Borchers","doi":"10.1007/s15004-018-6330-y","DOIUrl":"https://doi.org/10.1007/s15004-018-6330-y","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"1 1","pages":"40"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88782289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommt beim Myelom neue Elotuzumab-Kombination? 法官大人
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6306-y
Red.
{"title":"Kommt beim Myelom neue Elotuzumab-Kombination?","authors":"Red.","doi":"10.1007/s15004-018-6306-y","DOIUrl":"https://doi.org/10.1007/s15004-018-6306-y","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"58 1","pages":"54 - 54"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85063335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
aTTP: Erstes spezifisches Therapeutikum zugelassen 接受最佳治疗授权
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6304-0
Red.
{"title":"aTTP: Erstes spezifisches Therapeutikum zugelassen","authors":"Red.","doi":"10.1007/s15004-018-6304-0","DOIUrl":"https://doi.org/10.1007/s15004-018-6304-0","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"292 1","pages":"53 - 53"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79512267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bestrahlung als Prophylaxe 放射线放射
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6283-1
Christian Behrend
{"title":"Bestrahlung als Prophylaxe","authors":"Christian Behrend","doi":"10.1007/s15004-018-6283-1","DOIUrl":"https://doi.org/10.1007/s15004-018-6283-1","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"58 1","pages":"31"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81457307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zulassungserweiterung bei B-Zell-Vorläufer ALL 前身b细胞授权
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6303-1
Red.
{"title":"Zulassungserweiterung bei B-Zell-Vorläufer ALL","authors":"Red.","doi":"10.1007/s15004-018-6303-1","DOIUrl":"https://doi.org/10.1007/s15004-018-6303-1","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"37 1","pages":"53 - 53"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81870031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kombination aus Nivolumab und Ipilimumab auch bei Hirnmetastasen hoch effektiv! 如果我是你的朋友?
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6270-6
A. Schalhorn
{"title":"Kombination aus Nivolumab und Ipilimumab auch bei Hirnmetastasen hoch effektiv!","authors":"A. Schalhorn","doi":"10.1007/s15004-018-6270-6","DOIUrl":"https://doi.org/10.1007/s15004-018-6270-6","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"62 1","pages":"22-23"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76376236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nach Nilotinib-Absetzen lange therapiefrei 爸爸，听我说
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6300-4
F. Klein
{"title":"Nach Nilotinib-Absetzen lange therapiefrei","authors":"F. Klein","doi":"10.1007/s15004-018-6300-4","DOIUrl":"https://doi.org/10.1007/s15004-018-6300-4","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"3 1","pages":"52 - 52"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87476764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hochrisiko-Endometriumkarzinom: Immer eine adjuvante Radiochemotherapie? 病人的子宫内膜异位综合症?
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6271-5
F. Bock, G. Hildebrandt
{"title":"Hochrisiko-Endometriumkarzinom: Immer eine adjuvante Radiochemotherapie?","authors":"F. Bock, G. Hildebrandt","doi":"10.1007/s15004-018-6271-5","DOIUrl":"https://doi.org/10.1007/s15004-018-6271-5","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"35 1","pages":"24-25"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91210783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hoffnung oder Hype? Adoptive Immunzellen im Kampf gegen Brustkrebs 希望还是夸张?对抗乳癌的被领养免疫细胞
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6285-z
M. Borchers
{"title":"Hoffnung oder Hype? Adoptive Immunzellen im Kampf gegen Brustkrebs","authors":"M. Borchers","doi":"10.1007/s15004-018-6285-z","DOIUrl":"https://doi.org/10.1007/s15004-018-6285-z","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"50 1","pages":"31"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72876169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Checkpointhemmung nach erfolgreicher Radiochemotherapie zugelassen 接受了成功的无线电化学治疗
Info Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15004-018-6299-6
Red.
{"title":"Checkpointhemmung nach erfolgreicher Radiochemotherapie zugelassen","authors":"Red.","doi":"10.1007/s15004-018-6299-6","DOIUrl":"https://doi.org/10.1007/s15004-018-6299-6","url":null,"abstract":"","PeriodicalId":13696,"journal":{"name":"Info Onkologie","volume":"1 1","pages":"52 - 52"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73015765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信